China Biosimilar of Remicade Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product. 

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Biosimilar of Remicade market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Biosimilar of Remicade market. Detailed analysis of key players, along with key growth strategies adopted by Biosimilar of Remicade industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Celltrion

    • Genentech (Roche Group

    • LG Life Sciences

    • Biocon

    • Novartis (Sandoz)

    • Hospira

    • Merck Serono (Merck Group)

    • ynthon Pharmaceuticals

    • Biogen idec Inc

    By Type:

    • 100mg/10ml

    • 500mg/50ml

    By End-User:

    • Blood Disorders

    • Oncology Diseases

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilar of Remicade Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Biosimilar of Remicade Market Size and Growth Rate of 100mg/10ml from 2016 to 2027

    • 1.3.2 China Biosimilar of Remicade Market Size and Growth Rate of 500mg/50ml from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Biosimilar of Remicade Market Size and Growth Rate of Blood Disorders from 2016 to 2027

    • 1.4.2 China Biosimilar of Remicade Market Size and Growth Rate of Oncology Diseases from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Biosimilar of Remicade Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biosimilar of Remicade by Major Types

    • 3.4.1 Market Size and Growth Rate of 100mg/10ml

    • 3.4.2 Market Size and Growth Rate of 500mg/50ml

    4 Segmentation of Biosimilar of Remicade Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biosimilar of Remicade by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Biosimilar of Remicade in Blood Disorders

    • 4.4.2 Market Size and Growth Rate of Biosimilar of Remicade in Oncology Diseases

    5 Market Analysis by Regions

    • 5.1 China Biosimilar of Remicade Production Analysis by Regions

    • 5.2 China Biosimilar of Remicade Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Biosimilar of Remicade Landscape Analysis

    • 6.1 North China Biosimilar of Remicade Landscape Analysis by Major Types

    • 6.2 North China Biosimilar of Remicade Landscape Analysis by Major End-Users

    7 Central China Biosimilar of Remicade Landscape Analysis

    • 7.1 Central China Biosimilar of Remicade Landscape Analysis by Major Types

    • 7.2 Central China Biosimilar of Remicade Landscape Analysis by Major End-Users

    8 South China Biosimilar of Remicade Landscape Analysis

    • 8.1 South China Biosimilar of Remicade Landscape Analysis by Major Types

    • 8.2 South China Biosimilar of Remicade Landscape Analysis by Major End-Users

    9 East China Biosimilar of Remicade Landscape Analysis

    • 9.1 East China Biosimilar of Remicade Landscape Analysis by Major Types

    • 9.2 East China Biosimilar of Remicade Landscape Analysis by Major End-Users

    10 Northeast China Biosimilar of Remicade Landscape Analysis

    • 10.1 Northeast China Biosimilar of Remicade Landscape Analysis by Major Types

    • 10.2 Northeast China Biosimilar of Remicade Landscape Analysis by Major End-Users

    11 Southwest China Biosimilar of Remicade Landscape Analysis

    • 11.1 Southwest China Biosimilar of Remicade Landscape Analysis by Major Types

    • 11.2 Southwest China Biosimilar of Remicade Landscape Analysis by Major End-Users

    12 Northwest China Biosimilar of Remicade Landscape Analysis

    • 12.1 Northwest China Biosimilar of Remicade Landscape Analysis by Major Types

    • 12.2 Northwest China Biosimilar of Remicade Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Celltrion

      • 13.1.1 Celltrion Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Genentech (Roche Group

      • 13.2.1 Genentech (Roche Group Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 LG Life Sciences

      • 13.3.1 LG Life Sciences Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Biocon

      • 13.4.1 Biocon Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Novartis (Sandoz)

      • 13.5.1 Novartis (Sandoz) Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Hospira

      • 13.6.1 Hospira Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Merck Serono (Merck Group)

      • 13.7.1 Merck Serono (Merck Group) Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 ynthon Pharmaceuticals

      • 13.8.1 ynthon Pharmaceuticals Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Biogen idec Inc

      • 13.9.1 Biogen idec Inc Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Biosimilar of Remicade Market Size and Growth Rate of 100mg/10ml from 2016 to 2027

    • Figure China Biosimilar of Remicade Market Size and Growth Rate of 500mg/50ml from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Biosimilar of Remicade Market Size and Growth Rate of Blood Disorders from 2016 to 2027

    • Figure China Biosimilar of Remicade Market Size and Growth Rate of Oncology Diseases from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Biosimilar of Remicade Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Biosimilar of Remicade Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Biosimilar of Remicade

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biosimilar of Remicade by Different Types from 2016 to 2027

    • Table Consumption Share of Biosimilar of Remicade by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of 100mg/10ml

    • Figure Market Size and Growth Rate of 500mg/50ml

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Biosimilar of Remicade by Different End-Users from 2016 to 2027

    • Table Consumption Share of Biosimilar of Remicade by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Blood Disorders

    • Figure Market Size and Growth Rate of Oncology Diseases

    • Table China Biosimilar of Remicade Production by Regions

    • Table China Biosimilar of Remicade Production Share by Regions

    • Figure China Biosimilar of Remicade Production Share by Regions in 2016

    • Figure China Biosimilar of Remicade Production Share by Regions in 2021

    • Figure China Biosimilar of Remicade Production Share by Regions in 2027

    • Table China Biosimilar of Remicade Consumption by Regions

    • Table China Biosimilar of Remicade Consumption Share by Regions

    • Figure China Biosimilar of Remicade Consumption Share by Regions in 2016

    • Figure China Biosimilar of Remicade Consumption Share by Regions in 2021

    • Figure China Biosimilar of Remicade Consumption Share by Regions in 2027

    • Table North China Biosimilar of Remicade Consumption by Types from 2016 to 2027

    • Table North China Biosimilar of Remicade Consumption Share by Types from 2016 to 2027

    • Figure North China Biosimilar of Remicade Consumption Share by Types in 2016

    • Figure North China Biosimilar of Remicade Consumption Share by Types in 2021

    • Figure North China Biosimilar of Remicade Consumption Share by Types in 2027

    • Table North China Biosimilar of Remicade Consumption by End-Users from 2016 to 2027

    • Table North China Biosimilar of Remicade Consumption Share by End-Users from 2016 to 2027

    • Figure North China Biosimilar of Remicade Consumption Share by End-Users in 2016

    • Figure North China Biosimilar of Remicade Consumption Share by End-Users in 2021

    • Figure North China Biosimilar of Remicade Consumption Share by End-Users in 2027

    • Table Central China Biosimilar of Remicade Consumption by Types from 2016 to 2027

    • Table Central China Biosimilar of Remicade Consumption Share by Types from 2016 to 2027

    • Figure Central China Biosimilar of Remicade Consumption Share by Types in 2016

    • Figure Central China Biosimilar of Remicade Consumption Share by Types in 2021

    • Figure Central China Biosimilar of Remicade Consumption Share by Types in 2027

    • Table Central China Biosimilar of Remicade Consumption by End-Users from 2016 to 2027

    • Table Central China Biosimilar of Remicade Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Biosimilar of Remicade Consumption Share by End-Users in 2016

    • Figure Central China Biosimilar of Remicade Consumption Share by End-Users in 2021

    • Figure Central China Biosimilar of Remicade Consumption Share by End-Users in 2027

    • Table South China Biosimilar of Remicade Consumption by Types from 2016 to 2027

    • Table South China Biosimilar of Remicade Consumption Share by Types from 2016 to 2027

    • Figure South China Biosimilar of Remicade Consumption Share by Types in 2016

    • Figure South China Biosimilar of Remicade Consumption Share by Types in 2021

    • Figure South China Biosimilar of Remicade Consumption Share by Types in 2027

    • Table South China Biosimilar of Remicade Consumption by End-Users from 2016 to 2027

    • Table South China Biosimilar of Remicade Consumption Share by End-Users from 2016 to 2027

    • Figure South China Biosimilar of Remicade Consumption Share by End-Users in 2016

    • Figure South China Biosimilar of Remicade Consumption Share by End-Users in 2021

    • Figure South China Biosimilar of Remicade Consumption Share by End-Users in 2027

    • Table East China Biosimilar of Remicade Consumption by Types from 2016 to 2027

    • Table East China Biosimilar of Remicade Consumption Share by Types from 2016 to 2027

    • Figure East China Biosimilar of Remicade Consumption Share by Types in 2016

    • Figure East China Biosimilar of Remicade Consumption Share by Types in 2021

    • Figure East China Biosimilar of Remicade Consumption Share by Types in 2027

    • Table East China Biosimilar of Remicade Consumption by End-Users from 2016 to 2027

    • Table East China Biosimilar of Remicade Consumption Share by End-Users from 2016 to 2027

    • Figure East China Biosimilar of Remicade Consumption Share by End-Users in 2016

    • Figure East China Biosimilar of Remicade Consumption Share by End-Users in 2021

    • Figure East China Biosimilar of Remicade Consumption Share by End-Users in 2027

    • Table Northeast China Biosimilar of Remicade Consumption by Types from 2016 to 2027

    • Table Northeast China Biosimilar of Remicade Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Biosimilar of Remicade Consumption Share by Types in 2016

    • Figure Northeast China Biosimilar of Remicade Consumption Share by Types in 2021

    • Figure Northeast China Biosimilar of Remicade Consumption Share by Types in 2027

    • Table Northeast China Biosimilar of Remicade Consumption by End-Users from 2016 to 2027

    • Table Northeast China Biosimilar of Remicade Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Biosimilar of Remicade Consumption Share by End-Users in 2016

    • Figure Northeast China Biosimilar of Remicade Consumption Share by End-Users in 2021

    • Figure Northeast China Biosimilar of Remicade Consumption Share by End-Users in 2027

    • Table Southwest China Biosimilar of Remicade Consumption by Types from 2016 to 2027

    • Table Southwest China Biosimilar of Remicade Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Biosimilar of Remicade Consumption Share by Types in 2016

    • Figure Southwest China Biosimilar of Remicade Consumption Share by Types in 2021

    • Figure Southwest China Biosimilar of Remicade Consumption Share by Types in 2027

    • Table Southwest China Biosimilar of Remicade Consumption by End-Users from 2016 to 2027

    • Table Southwest China Biosimilar of Remicade Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Biosimilar of Remicade Consumption Share by End-Users in 2016

    • Figure Southwest China Biosimilar of Remicade Consumption Share by End-Users in 2021

    • Figure Southwest China Biosimilar of Remicade Consumption Share by End-Users in 2027

    • Table Northwest China Biosimilar of Remicade Consumption by Types from 2016 to 2027

    • Table Northwest China Biosimilar of Remicade Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Biosimilar of Remicade Consumption Share by Types in 2016

    • Figure Northwest China Biosimilar of Remicade Consumption Share by Types in 2021

    • Figure Northwest China Biosimilar of Remicade Consumption Share by Types in 2027

    • Table Northwest China Biosimilar of Remicade Consumption by End-Users from 2016 to 2027

    • Table Northwest China Biosimilar of Remicade Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Biosimilar of Remicade Consumption Share by End-Users in 2016

    • Figure Northwest China Biosimilar of Remicade Consumption Share by End-Users in 2021

    • Figure Northwest China Biosimilar of Remicade Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Celltrion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion

    • Figure Sales and Growth Rate Analysis of Celltrion

    • Figure Revenue and Market Share Analysis of Celltrion

    • Table Product and Service Introduction of Celltrion

    • Table Company Profile and Development Status of Genentech (Roche Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech (Roche Group

    • Figure Sales and Growth Rate Analysis of Genentech (Roche Group

    • Figure Revenue and Market Share Analysis of Genentech (Roche Group

    • Table Product and Service Introduction of Genentech (Roche Group

    • Table Company Profile and Development Status of LG Life Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LG Life Sciences

    • Figure Sales and Growth Rate Analysis of LG Life Sciences

    • Figure Revenue and Market Share Analysis of LG Life Sciences

    • Table Product and Service Introduction of LG Life Sciences

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Company Profile and Development Status of Novartis (Sandoz)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis (Sandoz)

    • Figure Sales and Growth Rate Analysis of Novartis (Sandoz)

    • Figure Revenue and Market Share Analysis of Novartis (Sandoz)

    • Table Product and Service Introduction of Novartis (Sandoz)

    • Table Company Profile and Development Status of Hospira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira

    • Figure Sales and Growth Rate Analysis of Hospira

    • Figure Revenue and Market Share Analysis of Hospira

    • Table Product and Service Introduction of Hospira

    • Table Company Profile and Development Status of Merck Serono (Merck Group)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Serono (Merck Group)

    • Figure Sales and Growth Rate Analysis of Merck Serono (Merck Group)

    • Figure Revenue and Market Share Analysis of Merck Serono (Merck Group)

    • Table Product and Service Introduction of Merck Serono (Merck Group)

    • Table Company Profile and Development Status of ynthon Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ynthon Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of ynthon Pharmaceuticals

    • Figure Revenue and Market Share Analysis of ynthon Pharmaceuticals

    • Table Product and Service Introduction of ynthon Pharmaceuticals

    • Table Company Profile and Development Status of Biogen idec Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen idec Inc

    • Figure Sales and Growth Rate Analysis of Biogen idec Inc

    • Figure Revenue and Market Share Analysis of Biogen idec Inc

    • Table Product and Service Introduction of Biogen idec Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.